Logo image of CHG.DE

CHAPTERS GROUP AG (CHG.DE) Stock Fundamental Analysis

FRA:CHG - Deutsche Boerse Ag - DE0006618309 - Common Stock - Currency: EUR

43  -0.1 (-0.23%)

Fundamental Rating

3

CHG gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 50 industry peers in the Financial Services industry. CHG scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CHG shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year CHG has reported negative net income.
CHG had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CHG reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CHG reported negative operating cash flow in multiple years.
CHG.DE Yearly Net Income VS EBIT VS OCF VS FCFCHG.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

1.2 Ratios

CHG has a worse Return On Assets (-3.46%) than 84.00% of its industry peers.
With a Return On Equity value of -5.46%, CHG is not doing good in the industry: 82.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.46%
ROE -5.46%
ROIC N/A
ROA(3y)-3.47%
ROA(5y)-1.12%
ROE(3y)-5.22%
ROE(5y)-0.89%
ROIC(3y)N/A
ROIC(5y)N/A
CHG.DE Yearly ROA, ROE, ROICCHG.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

CHG has a Gross Margin of 81.23%. This is in the better half of the industry: CHG outperforms 74.00% of its industry peers.
CHG's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for CHG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 81.23%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-4.07%
CHG.DE Yearly Profit, Operating, Gross MarginsCHG.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20K -20K 40K -40K 60K

4

2. Health

2.1 Basic Checks

CHG does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CHG has been increased compared to 1 year ago.
CHG has more shares outstanding than it did 5 years ago.
The debt/assets ratio for CHG has been reduced compared to a year ago.
CHG.DE Yearly Shares OutstandingCHG.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CHG.DE Yearly Total Debt VS Total AssetsCHG.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

CHG has an Altman-Z score of 4.77. This indicates that CHG is financially healthy and has little risk of bankruptcy at the moment.
CHG has a Altman-Z score of 4.77. This is in the better half of the industry: CHG outperforms 74.00% of its industry peers.
The Debt to FCF ratio of CHG is 4.06, which is a neutral value as it means it would take CHG, 4.06 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.06, CHG is in the better half of the industry, outperforming 72.00% of the companies in the same industry.
CHG has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.
CHG's Debt to Equity ratio of 0.07 is fine compared to the rest of the industry. CHG outperforms 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 4.06
Altman-Z 4.77
ROIC/WACCN/A
WACC6.98%
CHG.DE Yearly LT Debt VS Equity VS FCFCHG.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

CHG has a Current Ratio of 0.97. This is a bad value and indicates that CHG is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of CHG (0.97) is worse than 68.00% of its industry peers.
CHG has a Quick Ratio of 0.97. This is a bad value and indicates that CHG is not financially healthy enough and could expect problems in meeting its short term obligations.
CHG's Quick ratio of 0.92 is on the low side compared to the rest of the industry. CHG is outperformed by 64.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.92
CHG.DE Yearly Current Assets VS Current LiabilitesCHG.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

7

3. Growth

3.1 Past

CHG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -48.47%.
Looking at the last year, CHG shows a very strong growth in Revenue. The Revenue has grown by 56.39%.
Measured over the past years, CHG shows a very strong growth in Revenue. The Revenue has been growing by 308.75% on average per year.
EPS 1Y (TTM)-48.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-116.32%
Revenue 1Y (TTM)56.39%
Revenue growth 3Y3228.95%
Revenue growth 5Y308.75%
Sales Q2Q%63.43%

3.2 Future

CHG is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 94.37% yearly.
CHG is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 22.27% yearly.
EPS Next Y116.67%
EPS Next 2Y94.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year30.01%
Revenue Next 2Y22.27%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
CHG.DE Yearly Revenue VS EstimatesCHG.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M
CHG.DE Yearly EPS VS EstimatesCHG.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 0 0.2 0.4 0.6 0.8 1

2

4. Valuation

4.1 Price/Earnings Ratio

CHG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 54.58, CHG can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, CHG is valued a bit more expensive than the industry average as 74.00% of the companies are valued more cheaply.
CHG is valuated rather expensively when we compare the Price/Forward Earnings ratio to 37.64, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 54.58
CHG.DE Price Earnings VS Forward Price EarningsCHG.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 -60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHG indicates a slightly more expensive valuation: CHG is more expensive than 70.00% of the companies listed in the same industry.
64.00% of the companies in the same industry are cheaper than CHG, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 68.96
EV/EBITDA 101.88
CHG.DE Per share dataCHG.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

CHG's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CHG's earnings are expected to grow with 94.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y94.37%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

CHG does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CHAPTERS GROUP AG

FRA:CHG (7/25/2025, 7:00:00 PM)

43

-0.1 (-0.23%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)05-22 2025-05-22
Earnings (Next)N/A N/A
Inst Owners6.79%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.01B
Analysts80
Price Target49.98 (16.23%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)36.11%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 54.58
P/S 9.11
P/FCF 68.96
P/OCF 52.73
P/B 4.49
P/tB 59.67
EV/EBITDA 101.88
EPS(TTM)-0.54
EYN/A
EPS(NY)0.79
Fwd EY1.83%
FCF(TTM)0.62
FCFY1.45%
OCF(TTM)0.82
OCFY1.9%
SpS4.72
BVpS9.57
TBVpS0.72
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.46%
ROE -5.46%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 81.23%
FCFM 13.22%
ROA(3y)-3.47%
ROA(5y)-1.12%
ROE(3y)-5.22%
ROE(5y)-0.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-4.07%
F-Score4
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 4.06
Debt/EBITDA 1.64
Cap/Depr 22.14%
Cap/Sales 4.07%
Interest Coverage N/A
Cash Conversion 196.18%
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.92
Altman-Z 4.77
F-Score4
WACC6.98%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-48.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-116.32%
EPS Next Y116.67%
EPS Next 2Y94.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)56.39%
Revenue growth 3Y3228.95%
Revenue growth 5Y308.75%
Sales Q2Q%63.43%
Revenue Next Year30.01%
Revenue Next 2Y22.27%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-106.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year162.04%
EBIT Next 3Y54.75%
EBIT Next 5Y59.64%
FCF growth 1Y59.09%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y50.05%
OCF growth 3YN/A
OCF growth 5YN/A